COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > Keep going.....

<< Previous

Bullboard Posts

Next >>

Comment by Ciaoon Jul 10, 2024 7:15pm

108 Views

Post# 36127420

RE:RE:Keep going.....

That appears to be the m.o. No stopping them unless OATs decides to. Those concessions that he asked for pre-merger did not pan out. It shows how he was used for the new grift. New shareholders need to be warned.

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo